SPRINGFIELD, Ill. – The Illinois Department of Public Health (IDPH) has approved four new conditions for treatment with medicinal cannabis, a first in six years. Approved under Illinois law following ...

A pain-relieving medication might be safer for seniors than first thought.A new study published Jan. 7 in the Annals ...

Silo Pharma (NASDAQ: SILO) received a Notice of Allowance from the U.S. Patent and Trademark Office for a key patent supporting its lead asset, SPC- ...

Mr. Ainsworth brings over two decades of industry and market access experience to Tonix U.S. Food and Drug Administration ...

It is estimated that about a third of the population live with some form of muscle or joint problem and those most severely ...

Incident use of gabapentin is not associated with an increase in fall-related hospital visits compared with duloxetine ...

A systematic review of randomized controlled trials (RCTs) assessed the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for obesity in adults without ...

Coping with fibromyalgia as a parent can feel overwhelming, but avoiding common pitfalls makes a big difference. In this ...

New use of gabapentin (Neurontin) was not associated with greater risk of falls in older adults with neuropathy or ...

For people suffering from chronic knee pain, especially those over 50, a new treatment is offering hope and relief.

The prescription drug Cymbalta, generically duloxetine, is under recall for cancer-causing impurities that may have occurred naturally.

IND submission for intranasal SPC-15 treatment expected in 2025; Phase 1 clinical trial to follow upon approvalSP-26 ketamine implants nearing ...